GHK-Cu works through copper-dependent enzyme activity, extracellular matrix signaling, integrin pathways, MAPK/ERK cascades, and direct gene expression modulation
It's all so very complicated that you would probably benefit from seeing your GP, who should try and to sort this out for you
Multi-pathway engagement (ECM, oxidative stress, inflammatory tone)
You can also send a WhatsApp to 060 011 0211
Peter also dives into the potential upside of GLP-1s beyond weight loss and what evidence would justify broader use, explains why transcranial magnetic stimulation is on his radar, and shares his framework for evaluating body fat percentage
Theoretically, they operate through different mechanisms: semaglutide suppresses appetite and slows gastric emptying via GLP-1 receptors, while AOD 9604 acts on beta-3 adrenergic receptors on fat cells